Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
ORION-8 Trial: Leqvio (Inclisiran) + Statin Therapy Provides Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Beyond Six Years
08/28/2023

Novartis News

Novartis News
ORION-8, the largest clinical trial completed to date with Leqvio, continues to support the consistent long-term efficacy, safety, and tolerability of Leqvio, with a total exposure of more than 8,500 patient-years during the trial’s...
ORION-8, the largest clinical trial completed to date with Leqvio, continues to support the consistent long-term efficacy, safety, and tolerability of Leqvio, with a total exposure of more than 8,500 patient-years during the trial’s...
ORION-8, the largest clinical...
08/28/2023
Cath Lab Digest
News
Merck Initiates Phase 3 Clinical Program for Oral PCSK9 Inhibitor Candidate MK-0616
08/25/2023

Merck News

Merck News
Merck’s broad, global Phase 3 program for MK-0616 aims to enroll approximately 17,000 participants across the CORALreef Lipids, CORALreef HeFH and CORALreef Outcomes studies.
Merck’s broad, global Phase 3 program for MK-0616 aims to enroll approximately 17,000 participants across the CORALreef Lipids, CORALreef HeFH and CORALreef Outcomes studies.
Merck’s broad, global Phase 3...
08/25/2023
Cath Lab Digest

Advertisement

News
Philips Integrates AI in Cardiac Ultrasound and Across Cardiac Care at ESC 2023
08/25/2023

Royal Philips News

Royal Philips News
The portable Philips Ultrasound Compact System 5500 CV includes an AI-powered automation tool (the automated strain quantification) to assess the function of the heart’s left ventricle.
The portable Philips Ultrasound Compact System 5500 CV includes an AI-powered automation tool (the automated strain quantification) to assess the function of the heart’s left ventricle.
The portable Philips Ultrasound...
08/25/2023
Cath Lab Digest
News
SWEDEHEART Registry: Experiencing Pain After a Heart Attack May Predict Long-Term Survival
08/23/2023

American Heart Association News

American Heart Association News ...
In this study, participants who said they had extreme pain after a heart attack were more than twice as likely to die during the study period compared to those who reported no pain.
In this study, participants who said they had extreme pain after a heart attack were more than twice as likely to die during the study period compared to those who reported no pain.
In this study, participants who...
08/23/2023
Cath Lab Digest
News
NIH Awards The Texas Heart Institute $1.14 Million to Develop Novel, First-in-Class Drug for Atherosclerotic CVD
08/23/2023

The Texas Heart Institute News

The Texas Heart Institute News ...
In this project — funded under the NHLBI Catalyze Program — this new strategy will enable the suppression of white blood cell activation within atherosclerotic plaques beforehand by inhibiting the production of pro-inflammatory mediators...
In this project — funded under the NHLBI Catalyze Program — this new strategy will enable the suppression of white blood cell activation within atherosclerotic plaques beforehand by inhibiting the production of pro-inflammatory mediators...
In this project — funded under...
08/23/2023
Cath Lab Digest

Advertisement

News
AHA: Heart Attack and Stroke Survivors Neglect LDL Cholesterol Despite Increased Risk
08/23/2023

American Heart Association News

American Heart Association News ...
A survey from the American Heart Association showed 75% of heart attack and stroke survivors reported having high cholesterol.
A survey from the American Heart Association showed 75% of heart attack and stroke survivors reported having high cholesterol.
A survey from the American Heart...
08/23/2023
Cath Lab Digest
News
Playing Catch-Up on Weekends May Not Improve Cardiovascular Cost of Sleep Loss
08/23/2023

Penn State News

Penn State News
New research led by Penn State reveals that cardiovascular health measures, including heart rate and blood pressure, worsen over the course of the week when sleep is restricted to five hours per night, and attempting to catch up on sleep over...
New research led by Penn State reveals that cardiovascular health measures, including heart rate and blood pressure, worsen over the course of the week when sleep is restricted to five hours per night, and attempting to catch up on sleep over...
New research led by Penn State...
08/23/2023
Cath Lab Digest
News
Recor Medical and Otsuka Medical Devices Announce Positive Vote From U.S. FDA Advisory Committee on  Paradise Ultrasound Renal Denervation System
08/23/2023

Recor Medical News

Recor Medical News
Recor has reported positive outcomes in three independent, randomized, sham-controlled studies of the Paradise system in patients with mild-to-moderate and resistant hypertension.
Recor has reported positive outcomes in three independent, randomized, sham-controlled studies of the Paradise system in patients with mild-to-moderate and resistant hypertension.
Recor has reported positive...
08/23/2023
Cath Lab Digest

Advertisement

News
AHA: COVID-19 May Trigger New-Onset High Blood Pressure
08/22/2023

American Heart Association News

American Heart Association News ...
This retrospective observational study is the first to investigate the development and risk factors associated with persistent high blood pressure in people with COVID-19 infection compared to influenza, a similar respiratory virus.
This retrospective observational study is the first to investigate the development and risk factors associated with persistent high blood pressure in people with COVID-19 infection compared to influenza, a similar respiratory virus.
This retrospective observational...
08/22/2023
Cath Lab Digest
News
JACC: Genetic Study Shows Clopidogrel May Be Ineffective for Majority of British South Asians
08/22/2023

Queen Mary University of London News

Queen Mary University of London News ...
The research team was able to show that people with two loss of function CYP2C19 variants were more than three times more likely to have recurrent heart attacks, which may relate to clopidogrel treatment failure.
The research team was able to show that people with two loss of function CYP2C19 variants were more than three times more likely to have recurrent heart attacks, which may relate to clopidogrel treatment failure.
The research team was able to...
08/22/2023
Cath Lab Digest

Advertisement

Advertisement

Subscriber

Cath Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use